Jacobs and Pfizer Provide Sterile Drug Product Manufacturing Technology to Emerging Markets

PASADENA, Calif.--(BUSINESS WIRE)-- Jacobs Engineering Group Inc. (NYSE:JEC) announced today a collaboration with Pfizer Inc. on a modular process system to address the rapidly changing requirements of localized pharmaceutical manufacturing in emerging market countries.

The collaboration brings together Pfizer’s aseptic drug product process expertise and Jacobs’ capabilities in modular engineering, fabrication, and testing to create a Rapid Deployment Module (RDM) that integrates modular equipment, fully-automated control systems and single-use technology for bags, mixers, sterile connectors, manifolds and filters. The portable system is scalable for different batch sizes, adaptable for various products and can be rapidly deployed, and offers significant cost and schedule advantages compared to large manufacturing facilities with fixed equipment and limited flexibility.

In making the announcement, Jacobs Group Vice President Chris Nagel stated, “We are very pleased to be collaborating with Pfizer on this initiative to help meet the diverse medical needs of patients in emerging markets around the world. Our system uses off-the-shelf technology that requires minimal space and utilities. It is a process that can be replicated globally and offers a number of potential benefits such as reduced equipment, validation and operating costs; and compressed production cycles and training requirements.”

Kevin Nepveux, Vice President of Pfizer’s Global Technical Services, remarked, “The Rapid Deployment Module we developed with Jacobs has improved the quality and speed of our technology transfers by making our process more robust through specific engineering solutions. This system embodies the innovation culture that we strive for.”

The production systems are currently in their final stages of validation at a number of local pharmaceutical manufacturing sites around the world.

Jacobs is one of the world's largest and most diverse providers of technical professional and construction services.

Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2013 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.

Source: Jacobs Engineering Group Inc.

Jacobs Engineering Group Inc.

Michelle Jones, 626.578.6968